Endoscopy Systems

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

FDA OFFICE OF ACQ GRANT SVCS

Contract Value

Not provided

Codes & Classification
Solicitation Number

75F40126Q00381

NAICS

423490 - Other Professional Equipment and Supplies Merchant Wholesalers

Classification Code

6640

Additional Details
Set Aside

NONE

Place of Performance

Silver Spring, Maryland, UNITED STATES

SourceSAM
Documents3
The Food and Drug Administration (FDA), under the Department of Health and Human Services, has issued a Combined Synopsis/Solicitation for the procurement of an endoscopy system to support scientific research within the Office of Science and Engineering Laboratories (OSEL), Division of Imaging, Diagnostics, and Software Reliability (DIDSR). This initiative is guided by FDA requirements and aims to enhance the agency’s capacity for bench testing and evaluation of endoscopy devices, thereby advancing the safety and effectiveness of medical technologies. The scope of this procurement encompasses the acquisition and delivery of a fully integrated endoscope system, which will be utilized by OSEL researchers to develop and refine testing methodologies. The system must include interoperable components—specifically, a video processor, colonoscope, medical display, and cart—that, once assembled, function as a cohesive unit capable of acquiring and displaying live images. The endoscope system is to be delivered to the FDA facility at 10903 New Hampshire Ave WO62-3133, Silver Spring, Maryland 20993, with shipping costs incorporated into the total purchase price. Key requirements for the endoscope system are as follows: - **Video Processor:** Must be an FDA-cleared 510(k) medical device, with an integrated light source utilizing three or more LEDs to synthesize various spectra. The processor must support white light mode, at least two narrow-band imaging (NBI) modes (FDA-cleared for visualizing biological features), and at least two digital color enhancement modes (FDA-cleared under product code “PEA”). Video output ports must include 12G-SDI (3840x2160x60p), 3G-SDI (1920x1080x60p), and HD-SDI (1900x1080x60i). The processor must be capable of saving still images in standard formats (TIFF or JPEG) and video clips in standard video formats. - **Colonoscope:** Must be an FDA-cleared 510(k) device with forward viewing, a field of view of 170° or wider, depth of field covering 5-100 mm or more, angulation of at least 180°/180°/160°/160° (up/down/right/left), a water nozzle, insertion tube diameter of 12.8 mm or smaller, and an instrument channel diameter of 3.7 mm or larger. - **Medical Display:** Must accept signal input via 12G-SDI, 3G-SDI, Display Port, HDMI, and DVI. The display must have a pixel count of at least 3840x2160 (4K) and a diagonal size of 32 inches or greater. - **Power Requirements:** All system components must operate on standard U.S. power (120 volts, 60 Hertz AC). - **Warranty and Delivery:** The contractor must provide a comprehensive one-year system warranty covering parts, labor, travel, and shipping costs to restore the system to OEM standards. Delivery is required within six weeks of contract award, with the warranty period commencing upon system acceptance. The procurement is classified under NAICS Code 423490 (Other Professional Equipment and Supplies Merchant Wholesalers, 2022) and Product Service Code 6640. There are no set-aside requirements for this solicitation, making it open to all qualified vendors. The place of performance is Silver Spring, Maryland, United States. The contracting entity is the FDA Office of Acquisition and Grant Services. Primary and secondary points of contact for this opportunity are Pamela T. Lee ([email protected], 240-402-3847) and Madeline Bryant ([email protected], 240-402-7611), respectively. Interested contractors should review the solicitation details and attachments available on SAM.gov (Opportunity ID: 098ad8ecd3e148fba56d1031d023ffe3) and ensure their proposed systems meet all specified technical and regulatory requirements. The opportunity remains active, with responses due by September 16, 2026. This procurement represents a critical investment in FDA’s research infrastructure, with the intended outcome of advancing the agency’s ability to evaluate and ensure the safety and effectiveness of endoscopy devices. Contractors with proven capabilities in supplying FDA-cleared endoscopy systems and related medical equipment are encouraged to consider this opportunity.